Nektar Therapeutics Reports Third Quarter 2025 Financial Results

Go back to Nektar Therapeutics Reports Third Quarter 2025 Financial Results
Nektar Therapeutics (NASDAQ: NKTR) Delayed: 73.38 -1.15 (1.54%)
Previous Close $74.53    52 Week High $19.98 
Open $75.10    52 Week Low $10.52 
Day High $76.23    P/E N/A 
Day Low $72.83    EPS $-1.45 
Volume 417,591